Company: FVN
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0001829126-25-005949
Chunk: 14

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-08-08
Form: 10-Q
Item: Part I, Item 1
Chunk 14
---
 2025 

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentration of credit
         risk consist of cash account in a financial institution which, at times may exceed
         the Federal depository insurance coverage of $250,000 and marketable securities held in Trust Account. The Company has not experienced losses
         on this account and management believes the Company is not exposed to significant
         risks on such account.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the IPO that were directly related to the IPO. Offering cost amounted to $1,845,513, consisting of $862,500 and $522,019 of underwriting commissions which were paid in cash and representative shares (57,500 ordinary shares) at the closing date of the IPO, respectively and $460,994 of other offering costs. The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A - “Expenses of Offering”. The Company allocates offering costs among public shares, public rights based on the relative fair values of public shares and public rights. Accordingly, $1,684,693 was allocated to public shares and charged to ordinary shares subject to possible redemption, and $160,820 was allocated to public rights and charged to shareholders’ equity.

Deferred Offering Costs

The Company complies with the requirements of ASC
340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — Expenses of Offering. Deferred offering costs consist
of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO or
the proposed offering of Consideration Shares in connection with the Business Combination and that will be charged to shareholder’s
equity upon the completion of the offering. Should the offering prove to be unsuccessful, these deferred costs, as well as additional
expenses to be incurred, will be charged to operations.

Fair Value of Financial Instruments

ASC Topic 820 “Fair Value Measurements and Disclosures” defines fair value, the methods used to measure fair value and the expanded disclosures about fair value measurements. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between the buyer and the seller at the measurement date. In determining fair value, the valuation techniques consistent with the market approach, income approach and cost approach shall be used to measure